Current Treatment for Benign Prostatic Hyperplasia - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Systematic reviews and meta‐analyses represent the uppermost ladders in the hierarchy of
evidence. Systematic reviews/meta‐analyses suggest preliminary or satisfactory clinical …

Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting
men, generally after the age of 50. The prevalence of this multifactorial disease increases …

Benign prostatic hyperplasia (BPH) is one of the most common urological diseases in aging
men. Because of its long latency, BPH is a good target for prevention. The aim of the study …

Benign prostatic hyperplasia (BPH) and its associated is one of the most common diagnoses
seen by the urologist, with previous studies estimating greater than half of the men having at …

Benign prostatic hyperplasia (BPH) is arguably the most common benign disease among
men. This disease is often associated with lower urinary tract symptoms (LUTS) in men and …

Abstract Ethnopharmacological relevance Prunus africana (Hook. f.) Kalkman (Rosaceae),
commonly known as “Pygeum” or “African cherry”, occurs in mainland montane forests …

Introduction Benign prostatic hyperplasia (BPH) is a major chronic disease affecting men,
and the therapeutic agents currently used to manage it have significant side effects. As a …

Ethnopharmacological relevance Benign prostatic hyperplasia (BPH) is a common
urological disorder of men. The ethnomedicinal use of an African plant Prunus africana …

Benign prostatic hyperplasia (BPH) is an age-related disease, affecting a majority of elderly
men worldwide. Medical management of BPH is an alternative to surgical treatment of this …